Trial Outcomes & Findings for IVPCA in the Management of Pain Following Major Intracranial Surgery (NCT NCT00286221)

NCT ID: NCT00286221

Last Updated: 2017-09-26

Results Overview

Patients' Numerical Rating Scale scores (0-10: 0 = no pain, 10 = worst imaginable pain)

Recruitment status

COMPLETED

Study phase

PHASE2/PHASE3

Target enrollment

159 participants

Primary outcome timeframe

Up to 16 hours

Results posted on

2017-09-26

Participant Flow

Participant milestones

Participant milestones
Measure
Supratentorial PCA Fentanyl
PCA fentanyl: Patient controlled analgesia (PCA) fentanyl 0.5 ug/kg with a dosing interval ("lockout") of 15 minutes and a maximal permitted dosage of 4 demand doses per hour, according to their randomized preoperative assignment. The PCA pump (CADD-Solis Ambulatory Infusion Pump; Smiths Medical, Dublin, OH) had a preprogrammed dose limit of 50 ug fentanyl, and this was the maximal PCA dose permitted
Supratentorial PRN Fentanyl
PRN fentanyl: IV fentanyl 25 to 50 ug every 30 minutes PRN (the maximal routine dose permitted in our Neurosciences Critical Care Unit (NCCU))
Infratentorial PCA Fentanyl
PCA fentanyl: PCA fentanyl 0.5 ug/kg with a dosing interval ("lockout") of 15 minutes and a maximal permitted dosage of 4 demand doses per hour, according to their randomized preoperative assignment. The PCA pump (CADD-Solis Ambulatory Infusion Pump; Smiths Medical, Dublin, OH) had a preprogrammed dose limit of 50 ug fentanyl, and this was the maximal PCA dose permitted
Infratentorial PRN Fentanyl
PRN fentanyl: IV fentanyl 25 to 50 ug every 30 minutes PRN (the maximal routine dose permitted in our Neurosciences Critical Care Unit (NCCU))
Overall Study
STARTED
39
40
40
40
Overall Study
COMPLETED
29
35
31
34
Overall Study
NOT COMPLETED
10
5
9
6

Reasons for withdrawal

Reasons for withdrawal
Measure
Supratentorial PCA Fentanyl
PCA fentanyl: Patient controlled analgesia (PCA) fentanyl 0.5 ug/kg with a dosing interval ("lockout") of 15 minutes and a maximal permitted dosage of 4 demand doses per hour, according to their randomized preoperative assignment. The PCA pump (CADD-Solis Ambulatory Infusion Pump; Smiths Medical, Dublin, OH) had a preprogrammed dose limit of 50 ug fentanyl, and this was the maximal PCA dose permitted
Supratentorial PRN Fentanyl
PRN fentanyl: IV fentanyl 25 to 50 ug every 30 minutes PRN (the maximal routine dose permitted in our Neurosciences Critical Care Unit (NCCU))
Infratentorial PCA Fentanyl
PCA fentanyl: PCA fentanyl 0.5 ug/kg with a dosing interval ("lockout") of 15 minutes and a maximal permitted dosage of 4 demand doses per hour, according to their randomized preoperative assignment. The PCA pump (CADD-Solis Ambulatory Infusion Pump; Smiths Medical, Dublin, OH) had a preprogrammed dose limit of 50 ug fentanyl, and this was the maximal PCA dose permitted
Infratentorial PRN Fentanyl
PRN fentanyl: IV fentanyl 25 to 50 ug every 30 minutes PRN (the maximal routine dose permitted in our Neurosciences Critical Care Unit (NCCU))
Overall Study
Protocol Violation
2
1
6
4
Overall Study
Unanticipated Neurosurgical Complication
6
3
3
2
Overall Study
Inability to trigger PCA
2
0
0
0
Overall Study
Unrecognized exclusion criteria met
0
1
0
0

Baseline Characteristics

IVPCA in the Management of Pain Following Major Intracranial Surgery

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Supratentorial PCA Fentanyl
n=29 Participants
PCA fentanyl: Patient controlled analgesia (PC fentanyl 0.5 ug/kg with a dosing interval ("lockout") of 15 minutes and a maximal permitted dosage of 4 demand doses per hour, according to their randomized preoperative assignment. The PCA pump (CADD-Solis Ambulatory Infusion Pump; Smiths Medical, Dublin, OH) had a preprogrammed dose limit of 50 ug fentanyl, and this was the maximal PCA dose permitted
Supratentorial PRN Fentanyl
n=35 Participants
PRN fentanyl: IV fentanyl 25 to 50 ug every 30 minutes pro re nata (PRN) (the maximal routine dose permitted in our Neurosciences Critical Care Unit (NCCU))
Infratentorial PCA Fentanyl
n=31 Participants
PCA fentanyl: PCA fentanyl 0.5 ug/kg with a dosing interval ("lockout") of 15 minutes and a maximal permitted dosage of 4 demand doses per hour, according to their randomized preoperative assignment. The PCA pump (CADD-Solis Ambulatory Infusion Pump; Smiths Medical, Dublin, OH) had a preprogrammed dose limit of 50 ug fentanyl, and this was the maximal PCA dose permitted
Infratentorial PRN Fentanyl
n=34 Participants
PRN fentanyl: IV fentanyl 25 to 50 ug every 30 minutes PRN (the maximal routine dose permitted in our Neurosciences Critical Care Unit (NCCU))
Total
n=129 Participants
Total of all reporting groups
Age, Continuous
48.2 years
STANDARD_DEVIATION 11.9 • n=5 Participants
47.8 years
STANDARD_DEVIATION 15.0 • n=7 Participants
45.4 years
STANDARD_DEVIATION 14.6 • n=5 Participants
41.4 years
STANDARD_DEVIATION 11.1 • n=4 Participants
45.6 years
STANDARD_DEVIATION 13.2 • n=21 Participants
Sex: Female, Male
Female
18 Participants
n=5 Participants
17 Participants
n=7 Participants
20 Participants
n=5 Participants
21 Participants
n=4 Participants
76 Participants
n=21 Participants
Sex: Female, Male
Male
11 Participants
n=5 Participants
18 Participants
n=7 Participants
11 Participants
n=5 Participants
13 Participants
n=4 Participants
53 Participants
n=21 Participants
Region of Enrollment
United States
29 Participants
n=5 Participants
35 Participants
n=7 Participants
31 Participants
n=5 Participants
34 Participants
n=4 Participants
129 Participants
n=21 Participants

PRIMARY outcome

Timeframe: Up to 16 hours

Patients' Numerical Rating Scale scores (0-10: 0 = no pain, 10 = worst imaginable pain)

Outcome measures

Outcome measures
Measure
Supratentorial PCA Fentanyl
n=29 Participants
PCA fentanyl: PCA fentanyl 0.5 ug/kg with a dosing interval ("lockout") of 15 minutes and a maximal permitted dosage of 4 demand doses per hour, according to their randomized preoperative assignment. The PCA pump (CADD-Solis Ambulatory Infusion Pump; Smiths Medical, Dublin, OH) had a preprogrammed dose limit of 50 ug fentanyl, and this was the maximal PCA dose permitted
Supratentorial PRN Fentanyl
n=35 Participants
PRN fentanyl: IV fentanyl 25 to 50 ug every 30 minutes PRN (the maximal routine dose permitted in our Neurosciences Critical Care Unit (NCCU))
Infratentorial PCA Fentanyl
n=31 Participants
PCA fentanyl: PCA fentanyl 0.5 ug/kg with a dosing interval ("lockout") of 15 minutes and a maximal permitted dosage of 4 demand doses per hour, according to their randomized preoperative assignment. The PCA pump (CADD-Solis Ambulatory Infusion Pump; Smiths Medical, Dublin, OH) had a preprogrammed dose limit of 50 ug fentanyl, and this was the maximal PCA dose permitted
Infratentorial PRN Fentanyl
n=34 Participants
PRN fentanyl: IV fentanyl 25 to 50 ug every 30 minutes PRN (the maximal routine dose permitted in our Neurosciences Critical Care Unit (NCCU))
Hourly Pain Scores
2.5 units on a scale
Standard Deviation 2.0
3.6 units on a scale
Standard Deviation 2.1
3.7 units on a scale
Standard Deviation 1.9
5.2 units on a scale
Standard Deviation 1.9

SECONDARY outcome

Timeframe: Up to 16 hours

the amount of fentanyl is that administered in response to corresponding rest pain levels. Thus, the 0 hour indicates the amount of fentanyl administered from the time of admission until the end of the first hour. Also note that once pain assessments are made every other hour (e.g., 10, 12, 14, and 16), the analgesic totals indicated are for the corresponding 2-hour period after the pain assessment, and were halved to estimate the hourly rate of analgesic consumption.

Outcome measures

Outcome measures
Measure
Supratentorial PCA Fentanyl
n=29 Participants
PCA fentanyl: PCA fentanyl 0.5 ug/kg with a dosing interval ("lockout") of 15 minutes and a maximal permitted dosage of 4 demand doses per hour, according to their randomized preoperative assignment. The PCA pump (CADD-Solis Ambulatory Infusion Pump; Smiths Medical, Dublin, OH) had a preprogrammed dose limit of 50 ug fentanyl, and this was the maximal PCA dose permitted
Supratentorial PRN Fentanyl
n=35 Participants
PRN fentanyl: IV fentanyl 25 to 50 ug every 30 minutes PRN (the maximal routine dose permitted in our Neurosciences Critical Care Unit (NCCU))
Infratentorial PCA Fentanyl
n=31 Participants
PCA fentanyl: PCA fentanyl 0.5 ug/kg with a dosing interval ("lockout") of 15 minutes and a maximal permitted dosage of 4 demand doses per hour, according to their randomized preoperative assignment. The PCA pump (CADD-Solis Ambulatory Infusion Pump; Smiths Medical, Dublin, OH) had a preprogrammed dose limit of 50 ug fentanyl, and this was the maximal PCA dose permitted
Infratentorial PRN Fentanyl
n=34 Participants
PRN fentanyl: IV fentanyl 25 to 50 ug every 30 minutes PRN (the maximal routine dose permitted in our Neurosciences Critical Care Unit (NCCU))
Fentanyl Consumption
44.1 mcg/hour
Standard Deviation 34.5
23.6 mcg/hour
Standard Deviation 23.7
54.8 mcg/hour
Standard Deviation 34.8
29.9 mcg/hour
Standard Deviation 16.4

Adverse Events

Supratentorial PCA Fentanyl

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Supratentorial PRN Fentanyl

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Infratentorial PCA Fentanyl

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Infratentorial PRN Fentanyl

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Bradford Winters

Johns Hopkins School of Medicine

Phone: 4109559080

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place